Seminars in Oncology Nursing
Volume 23, Issue 1 , Pages 46-54, February 2007

Advances in Hormonal Therapy for Breast Cancer

  • Nancy Jo Bush

      Affiliations

    • Corresponding Author InformationAddress correspondence to Nancy Jo Bush, RN, MN, MA, AOCN®, Premiere Oncology, 2020 Santa Monica Blvd, Suite 510, Santa Monica, CA 90404

Objectives

To describe recent developments in hormonal therapy for breast cancer, focusing on SERMs and AIs.

Data Sources

Published journal articles and texts, research reports and monographs, government publications, and professional organization guidelines.

Conclusion

Research continues to identify the effectiveness of hormonal therapy in breast cancer, including adjuvant treatment in early and advanced stages as well as a chemopreventive measure. The individual drug profile must be evaluated for safety and efficacy, and the impact on QOL must be considered.

Implications for Nursing Practice

It is imperative that oncology nurses understand the physiology, application, risks, and benefits of hormonal therapies.

Key Words: Hormonal therapy, SERM, Aromatase inhibitor, Menopausal symptoms

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(06)00161-6

doi:10.1016/j.soncn.2006.11.008

Seminars in Oncology Nursing
Volume 23, Issue 1 , Pages 46-54, February 2007

Article Tools